Companies / IO Biotech, Inc.

IO Biotech, Inc.

Foreign · IFRSCIK 1865494COPENHAGEN

Financials

Revenue—
Net income$-95.49M
Total debt$16.66M
Cash$30.66M
Diluted EPS$-1.45
Shares outstanding71.9M

Ownership

71.9M shares outstanding · as of Nov 10, 2025
6.3%10%+ / strategic
Ownership
10%+ / strategic6.31%4,543,532
Institutions11.29%8,123,930
Public float82.39%59,281,380

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 23

View all →
HolderValue% of shares
Novo Holdings A/S$1.53M3.49%
Ikarian Capital, LLC$844.3K1.93%
Bank of America Corp /De$486.4K1.11%
Morgan Stanley$328.3K0.75%
Beacon Pointe Advisors, LLC$308.1K0.70%
Boothbay Fund Management, LLC$275.1K0.63%
Dauntless Investment Group, LLC$275.0K0.63%
Renaissance Technologies LLC$126.4K0.29%
Citigroup Inc$67.9K0.15%
Bridgeway Capital Management, LLC$45.7K0.10%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Point72 Asset Management, L.P.Passive13G———
Chernett JoreyPassive13G/A—4,543,532—
HBM Healthcare Investments (Cayman) Ltd.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
———449778109—